{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:34Z","timestamp":1786120354208,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/dad.0b013e3182448f7c","type":"journal-article","created":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T07:46:47Z","timestamp":1331279207000},"page":"691-698","source":"Crossref","is-referenced-by-count":4,"title":["Mapping Toll-Like Receptor Activity in Different Stages of Cutaneous T-Cell Lymphoma"],"prefix":"10.1097","volume":"34","author":[{"given":"Jessica A.","family":"Kado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryann","family":"Shango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Mehregan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius R.","family":"Mehregan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210202","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/107327480701400203","article-title":". The diagnosis, staging, and treatment options for mycosis fungoides.","volume":"14","author":"Keehn","year":"2007","journal-title":"Cancer Control"},{"key":"R2-2-20210202","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-4632.2009.04111.x","article-title":"Toll-like receptors and dermatology.","volume":"48","author":"Petry","year":"2009","journal-title":"Int J Dermatol"},{"key":"R3-2-20210202","first-page":"636","article-title":". Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome).","volume":"16","author":"Jarrousse","year":"2006","journal-title":"Eur J Dermatol"},{"key":"R4-2-20210202","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.bbrc.2009.08.062","article-title":"Toll-like receptors and innate immunity.","volume":"388","author":"Kumar","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"R5-2-20210202","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00281-007-0061-8","article-title":"Toll-like receptors in the skin.","volume":"29","author":"Miller","year":"2007","journal-title":"Semin Immunopathol"},{"key":"R6-2-20210202","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.4049\/jimmunol.172.8.5056","article-title":". Human intestinal microvascular endothelial cells express Toll-like receptor 5: a binding partner for bacterial flagellin.","volume":"172","author":"Maaser","year":"2004","journal-title":"J Immunol"},{"key":"R7-2-20210202","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jaad.2005.05.004","article-title":"Toll-like receptors: applications to dermatologic disease.","volume":"54","author":"Kang","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R8-2-20210202","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1046\/j.1365-2133.2003.05287.x","article-title":". Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis.","volume":"148","author":"Baker","year":"2003","journal-title":"Br J Dermatol"},{"key":"R9-2-20210202","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1600-0560.2007.00756.x","article-title":". Comparison of expression of heat-shock protein 60, Toll-like receptors 2 and 4, and T-cell receptor gammadelta in plaque and guttate psoriasis.","volume":"34","author":"Seung","year":"2007","journal-title":"J Cutan Pathol"},{"key":"R10-2-20210202","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3346\/jkms.2008.23.2.307","article-title":". Expression of Toll-like receptors in verruca and molluscum contagiosum.","volume":"23","author":"Ku","year":"2008","journal-title":"J Korean Med Sci"},{"key":"R11-2-20210202","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0923-1811(02)00105-6","article-title":". Expression of functional Toll-like receptor 2 on human epidermal keratinocytes.","volume":"30","author":"Kawai","year":"2002","journal-title":"J Dermatol Sci"},{"key":"R12-2-20210202","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/intimm\/dxg068","article-title":". Expression and function of Toll-like receptors 2 and 4 in human keratinocytes.","volume":"15","author":"Pivarcsi","year":"2003","journal-title":"Int Immunol"},{"key":"R13-2-20210202","first-page":"420","article-title":". Effect of topical tacrolimus ointment on expression of Toll-like receptors 2 and 4 in lesional atopic dermatitis skin.","volume":"38","author":"Xie","year":"2006","journal-title":"Article in Chinese Beijing Da Xue Xue Bao"},{"key":"R14-2-20210202","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1523-1747.2002.01847.x","article-title":". Human keratinocytes express functional CD14 and toll-like receptor 4.","volume":"119","author":"Song","year":"2002","journal-title":"J Invest Dermatol"},{"key":"R15-2-20210202","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1523-1747.2003.12630.x","article-title":". Toll-like receptor expression in human keratinocytes: nuclear factor kappa B controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent.","volume":"121","author":"Mempel","year":"2003","journal-title":"J Invest Dermatol"},{"key":"R16-2-20210202","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.4049\/jimmunol.172.11.6545","article-title":". Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3.","volume":"172","author":"Kariko","year":"2004","journal-title":"J Immunol"},{"key":"R17-2-20210202","doi-asserted-by":"crossref","first-page":"178","DOI":"10.5858\/2003-127-178-IIRRIN","article-title":". Innate immune-related receptors in normal and psoriatic skin.","volume":"127","author":"Curry","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"R18-2-20210202","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.jid.5700530","article-title":". Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9.","volume":"127","author":"Lebre","year":"2007","journal-title":"J Invest Dermatol"},{"key":"R19-2-20210202","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/90609","article-title":"Toll-like receptors: critical proteins linking innate and acquired immunity.","volume":"2","author":"Akira","year":"2001","journal-title":"Nat Immunol"},{"key":"R20-2-20210202","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.4049\/jimmunol.166.3.2018","article-title":". Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation.","volume":"166","author":"Faure","year":"2001","journal-title":"J Immunol"},{"key":"R21-2-20210202","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1182\/blood-2008-07-166934","article-title":". Toll-like receptor 4 in lymphatic endothelial cells contributes to LPS-induced lymphangiogenesis by chemotactic recruitment of macrophages.","volume":"113","author":"Kang","year":"2009","journal-title":"Blood"},{"key":"R22-2-20210202","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1053\/hupa.2000.20370","article-title":". Constitutive expression of NF-kappaB is a characteristic feature of mycosis fungoides: implications for apoptosis resistance and pathogenesis.","volume":"31","author":"Izban","year":"2000","journal-title":"Hum Pathol"},{"key":"R23-2-20210202","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2005-06-2536","article-title":". Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis.","volume":"107","author":"Sors","year":"2006","journal-title":"Blood"},{"key":"R24-2-20210202","first-page":"148","article-title":". Imiquimod in mycosis fungoides.","volume":"18","author":"Martinez-Gonzalez","year":"2008","journal-title":"Eur J Dermatol"},{"key":"R25-2-20210202","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/cimm.1998.1406","article-title":". Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod.","volume":"191","author":"Wagner","year":"1999","journal-title":"Cell Immunol"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0b013e3182448f7c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:35:30Z","timestamp":1786048530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000372-201210000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0b013e3182448f7c","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}